Hypertension, Dyslipidaemia and Cardiometabolic Disease
Hypertension, Dyslipidaemia and Cardiometabolic Disease Read More »
To provide a national assessment of cardiovascular risk factors and disease mortality among Asian Indian, Chinese, and Filipino American subgroups in the United States.
In this study, we analyzed data from 45,250 participants from the National Health and Nutrition Examination Survey spanning 1999 to 2020. Using multivariable logistic regression, we explored the association between CMI and hypertension, employing Restricted Cubic Spline analysis to assess non-linear relationships and two-piecewise linear regression to identify threshold effects.
Discover the intricate connections between hypertension, dyslipidaemia, and cardiometabolic disease with our insightful infographic. Focusing on the Asia Pacific region, this visual guide delves into the pathophysiology, interplay, and therapeutic management of these prevalent conditions. Learn about shared risk factors, health implications, and effective strategies for prevention and treatment. Click to explore how integrated care and lifestyle modifications can make a difference in combating these interconnected health challenges.
[Mandarin Translation] Join Dr. Donna Lin as she presents a compelling case of a 62-year-old woman with hypertension, type 2 diabetes, obesity, and heart failure with preserved ejection fraction (HFpEF)—a complex clinical picture that exemplifies the challenges of cardio-kidney-metabolic (CKM) syndrome.
[Mandarin Translation] Managing Hypertension in the Context of Cardiometabolic Disease Read More »
Join Dr. Donna Lin as she presents a compelling case of a 62-year-old woman with hypertension, type 2 diabetes, obesity, and heart failure with preserved ejection fraction (HFpEF)—a complex clinical picture that exemplifies the challenges of cardio-kidney-metabolic (CKM) syndrome.
Managing Hypertension in the Context of Cardiometabolic Disease Read More »
• Gain valuable knowledge from leading experts in the field.
• Discover practical strategies for managing hypertension and dyslipidemia in diverse patient populations.
• Enhance your understanding of the regional nuances in prevalence and management of these conditions.
The purpose of this study was to examine the cardiovascular benefits of tirzepatide vs GLP-1RA in people living with overweight or obesity, with T2DM, age ≥40 years, and pre-existing ischemic heart disease (IHD).
In this clinical practice statement, we aim to provide a roadmap of the path forward in each of these domains for health care providers and health systems, community outreach groups, and stakeholders invested in investigation and policy to mitigate risk and empower SAs to lead healthy lives.
Asia is a large continent that comprises diverse populations with varying cultures, socioeconomic status, and health literacy levels. Effective preventive cardiology may require differential health care resource allocation and financing models.
Primary Prevention of Cardiovascular Disease in Asia: Challenges: A Narrative Review Read More »
This site is only for use by healthcare professionals.
By continuing to view this site you are confirming that you are a healthcare professional.